In 2026 U.S. prescription-claims data, atorvastatin calcium ranks as the most prescribed medicine by claim volume. The answer can differ by country, dataset, measurement period, and whether prescriptions, patients, or days of therapy are counted.
Answer
Atorvastatin is frequently identified as the most prescribed prescription medicine in the United States because of its widespread use in managing elevated cholesterol and reducing cardiovascular risk. A 2026 U.S. claims analysis reported atorvastatin calcium as the leading medicine by percentage of prescription claims.
Other medicines commonly appearing near the top include levothyroxine, lisinopril, metformin, amlodipine, and medications used for hypertension, thyroid replacement, diabetes, and cardiovascular-risk management. Rankings can differ substantially because databases may count:
• Individual prescriptions or refills
• Unique treated patients
• Prescription claims
• Tablets or dosage units
• Days of therapy
• Retail prescriptions only
• Hospital and institutional use
A 90-day prescription may be counted once even though it represents substantially more therapy than a 30-day prescription. Combination products, different strengths, and extended-release versions may also be aggregated differently.
There is no single global “most prescribed drug.” Disease prevalence, treatment guidelines, reimbursement, generic availability, healthcare access, and population demographics vary among countries. For market analysis, the country, care channel, data period, and counting methodology should always accompany the ranking. Current U.S. claims data support atorvastatin as the leading answer, but it should not be presented as a permanent worldwide fact.

Trust Our Expert Answers?

